Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1997 4
1998 1
1999 1
2000 1
2001 1
2002 1
2003 2
2004 2
2005 4
2006 3
2008 1
2009 1
2010 2
2012 3
2013 1
2014 2
2015 3
2016 4
2017 3
2019 2
2021 1
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Arrhythmogenic Right Ventricular Cardiomyopathy.
Krahn AD, Wilde AAM, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, Han HC. Krahn AD, et al. JACC Clin Electrophysiol. 2022 Apr;8(4):533-553. doi: 10.1016/j.jacep.2021.12.002. JACC Clin Electrophysiol. 2022. PMID: 35450611 Free article. Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right ventricular fibrofatty infiltration, with a predominant arrhythmic presentation. ...Risk stratification of patients with ARVC aims to …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right …
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.
Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP. Elliott PM, et al. Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18. Eur J Heart Fail. 2019. PMID: 31210398 Free PMC article. Review.
It is 35 years since the first description of arrhythmogenic right ventricular cardiomyopathy (ARVC) and more than 20 years since the first reports establishing desmosomal gene mutations as a major cause of the disease. ...In this paper, we present the conclu …
It is 35 years since the first description of arrhythmogenic right ventricular cardiomyopathy (ARVC) and more than 20 y …
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G. Buja G, et al. Prog Cardiovasc Dis. 2008 Jan-Feb;50(4):282-93. doi: 10.1016/j.pcad.2007.10.004. Prog Cardiovasc Dis. 2008. PMID: 18156007 Free PMC article. Review.
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occurs primarily in young and middle-age individuals. ...Heart failure may occur later in life secondary to slow, progressive loss of right …
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occ …
Arrhythmogenic right ventricular dysplasia.
Anderson EL. Anderson EL. Am Fam Physician. 2006 Apr 15;73(8):1391-8. Am Fam Physician. 2006. PMID: 16669561 Free article. Review.
Arrhythmogenic right ventricular dysplasia (ARVD) is a disorder in which normal myocardium is replaced by fibrofatty tissue. This disorder usually involves the right ventricle, but the left ventricle and septum also may be affected. ...
Arrhythmogenic right ventricular dysplasia (ARVD) is a disorder in which normal myocardium is replaced by fibrof …
Arrhythmogenic right ventricular dysplasia: cardiomyopathy current opinions on diagnostic and therapeutic aspects.
Naccarella F, Naccarelli G, Fattori R, Nava A, Martini B, Corrado D, Masotti A, Gatti M. Naccarella F, et al. Curr Opin Cardiol. 2001 Jan;16(1):8-16. doi: 10.1097/00001573-200101000-00002. Curr Opin Cardiol. 2001. PMID: 11124713 Review.
Right Ventricular Dysplasia constitutes a genetic cardiomyopathy characterized by fibrous-adipose substitution of the right and rarely of the left ventricular myocardium. This disorder is associated with ventricular arrhythmias ranging fr …
Right Ventricular Dysplasia constitutes a genetic cardiomyopathy characterized by fibrous-adipose substitution of the …
Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Hulot JS, et al. Circulation. 2004 Oct 5;110(14):1879-84. doi: 10.1161/01.CIR.0000143375.93288.82. Epub 2004 Sep 27. Circulation. 2004. PMID: 15451782 Review.
BACKGROUND: Management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is complicated by the incomplete information on the natural history of the disease and by the lack of risk stratification for cardiovascular deat …
BACKGROUND: Management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is co …
Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases.
Szentandrássy N, Magyar ZÉ, Hevesi J, Bányász T, Nánási PP, Almássy J. Szentandrássy N, et al. Int J Mol Sci. 2022 Apr 18;23(8):4435. doi: 10.3390/ijms23084435. Int J Mol Sci. 2022. PMID: 35457253 Free PMC article. Review.
Ryanopathies are associated with the impaired function of the RyR, leading to heart diseases such as congestive heart failure (CHF), catecholaminergic polymorphic ventricular tachycardia (CPVT), arrhythmogenic right ventricular dysplasia type 2 …
Ryanopathies are associated with the impaired function of the RyR, leading to heart diseases such as congestive heart failure (CHF), catecho …
Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis.
Saffitz JE, Asimaki A, Huang H. Saffitz JE, et al. J Investig Med. 2009 Dec;57(8):861-4. doi: 10.2310/JIM.0b013e3181c5e631. J Investig Med. 2009. PMID: 19952894 Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disorder characterized by the early occurrence of serious tachyarrhythmias often out of proportion to the extent of structural changes and contractile derangement. ...
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disorder characterized by the early oc …
Exercise-induced Ventricular Tachycardia/Ventricular Fibrillation in the Normal Heart: Risk Stratification and Management.
Michowitz Y, Viskin S, Rosso R. Michowitz Y, et al. Card Electrophysiol Clin. 2016 Sep;8(3):593-600. doi: 10.1016/j.ccep.2016.04.008. Epub 2016 Jun 18. Card Electrophysiol Clin. 2016. PMID: 27521092 Review.
Exercise-induced ventricular tachycardia (VT) rarely occurs in the absence of organic heart disease. ...The main aspect of the risk stratification process is recognizing subtle forms of organic heart disease, particularly arrhythmogenic right ventricular …
Exercise-induced ventricular tachycardia (VT) rarely occurs in the absence of organic heart disease. ...The main aspect of the risk s …
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF. Schinkel AF. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14. Circ Arrhythm Electrophysiol. 2013. PMID: 23673907 Review.
BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiomyopathy characterized by ventricular arrhythmias and an abnormal right ventricle. ...During the 3.8-year follow-up, annualized cardiac morta …
BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiomyopathy characterized …
48 results